GR3025892T3 - Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist. - Google Patents
Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist.Info
- Publication number
- GR3025892T3 GR3025892T3 GR980400065T GR980400065T GR3025892T3 GR 3025892 T3 GR3025892 T3 GR 3025892T3 GR 980400065 T GR980400065 T GR 980400065T GR 980400065 T GR980400065 T GR 980400065T GR 3025892 T3 GR3025892 T3 GR 3025892T3
- Authority
- GR
- Greece
- Prior art keywords
- exercise
- diagnosis
- evaluation
- responses
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/325—Applying electric currents by contact electrodes alternating or intermittent currents for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/56—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
- C07C215/58—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
- C07C215/60—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
- C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
- C07C45/305—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation with halogenochromate reagents, e.g. pyridinium chlorochromate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0448—Drug reservoir
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S128/00—Surgery
- Y10S128/13—Infusion monitoring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Radiology & Medical Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Electrotherapy Devices (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15787588A | 1988-02-19 | 1988-02-19 | |
US07/308,683 US5108363A (en) | 1988-02-19 | 1989-02-09 | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
EP89301553A EP0329464B1 (en) | 1988-02-19 | 1989-02-17 | System for the closed-loop administration of an exercise simulating agent |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3025892T3 true GR3025892T3 (en) | 1998-04-30 |
Family
ID=26854551
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960400162T GR3018764T3 (en) | 1988-02-19 | 1996-01-24 | System for the closed-loop administration of an exercise simulating agent. |
GR980400065T GR3025892T3 (en) | 1988-02-19 | 1998-01-14 | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR960400162T GR3018764T3 (en) | 1988-02-19 | 1996-01-24 | System for the closed-loop administration of an exercise simulating agent. |
Country Status (13)
Country | Link |
---|---|
US (4) | US5108363A (el) |
EP (2) | EP0658538B1 (el) |
JP (2) | JP2806543B2 (el) |
AT (2) | ATE159710T1 (el) |
AU (1) | AU634152B2 (el) |
DE (2) | DE68928422T2 (el) |
DK (1) | DK73589A (el) |
ES (2) | ES2081299T3 (el) |
FI (1) | FI890776A (el) |
GR (2) | GR3018764T3 (el) |
IE (2) | IE80716B1 (el) |
NO (1) | NO890704L (el) |
NZ (1) | NZ239270A (el) |
Families Citing this family (127)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6144385A (ja) * | 1984-08-07 | 1986-03-04 | Tokyu Constr Co Ltd | 構造物内の放射線吸収体の探査方法 |
IL82997A0 (en) * | 1986-07-11 | 1987-12-20 | Tanabe Seiyaku Co | Method for epimerizing an optically active benzyl alcohol derivative |
US5108363A (en) * | 1988-02-19 | 1992-04-28 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
AU629989B2 (en) * | 1989-10-10 | 1992-10-15 | Glaxo Group Limited | Phenethanolamine derivatives |
US5023085A (en) * | 1989-11-29 | 1991-06-11 | Pfizer Inc. | Transdermal flux enhancers in combination with iontophoresis in topical administration of pharmaceuticals |
US5607447A (en) * | 1993-09-28 | 1997-03-04 | Mcewen; James A. | Physiologic tourniquet |
US5254087A (en) * | 1990-01-29 | 1993-10-19 | Ivra Systems, Inc. | Tourniquet apparatus for intravenous regional anesthesia |
US5556415A (en) * | 1990-01-29 | 1996-09-17 | Mcewen; James A. | Physiologic tourniquet for intravenous regional anesthesia |
US5281623A (en) * | 1990-08-27 | 1994-01-25 | Eli Lilly And Company | Method for treating inflammation |
AU3071992A (en) * | 1991-11-13 | 1993-06-15 | Gensia, Inc. | Methods for increasing the sensitivity and decreasing the side effects of pharmacological stress testing for coronary artery disease |
IL104365A0 (en) * | 1992-01-31 | 1993-05-13 | Gensia Pharma | Method and apparatus for closed loop drug delivery |
HUT64459A (en) * | 1992-03-31 | 1994-01-28 | Richter Gedeon Vegyeszet | Process and apparatus for the diagnostics of cardiovascular |
US5752521A (en) | 1993-11-12 | 1998-05-19 | Dardik; Irving I. | Therapeutic exercise program |
US6397098B1 (en) * | 1994-09-21 | 2002-05-28 | Medrad, Inc. | Data communication and control for medical imaging systems |
US5840026A (en) * | 1994-09-21 | 1998-11-24 | Medrad, Inc. | Patient specific dosing contrast delivery systems and methods |
US5551953A (en) * | 1994-10-31 | 1996-09-03 | Alza Corporation | Electrotransport system with remote telemetry link |
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US5775329A (en) * | 1995-06-07 | 1998-07-07 | Gensia, Inc. | Method and compounds for diagnosing coronary artery disease |
US5855589A (en) * | 1995-08-25 | 1999-01-05 | Mcewen; James A. | Physiologic tourniquet for intravenous regional anesthesia |
US5931853A (en) * | 1995-08-25 | 1999-08-03 | Mcewen; James A. | Physiologic tourniquet with safety circuit |
US6430997B1 (en) | 1995-11-06 | 2002-08-13 | Trazer Technologies, Inc. | System and method for tracking and assessing movement skills in multidimensional space |
ES2159770T3 (es) * | 1995-12-22 | 2001-10-16 | Abbott Lab | Procedimiento mejorado de preparacion de intermediarios aldehidos de alquilo o de arilo. |
US5874601A (en) * | 1996-03-14 | 1999-02-23 | Abbott Laboratories | Process of protecting a 1,2-aminoalcohol for reductive amination coupling |
US5706822A (en) * | 1996-03-29 | 1998-01-13 | Kozz Incorporated | Method and computer program for creating individualized exercise protocols |
US5735814A (en) * | 1996-04-30 | 1998-04-07 | Medtronic, Inc. | Techniques of treating neurodegenerative disorders by brain infusion |
US5711316A (en) * | 1996-04-30 | 1998-01-27 | Medtronic, Inc. | Method of treating movement disorders by brain infusion |
US5713923A (en) * | 1996-05-13 | 1998-02-03 | Medtronic, Inc. | Techniques for treating epilepsy by brain stimulation and drug infusion |
WO1998024753A1 (fr) * | 1996-12-02 | 1998-06-11 | Chisso Corporation | Derives de nitro-alcool actifs optiquement, derives d'amino-alcool actifs optiquement et leur procede de preparation |
US6018679A (en) * | 1997-01-29 | 2000-01-25 | Novartis Finance Corp. | Iontophoretic transdermal delivery and control of adverse side-effects |
CN1311877C (zh) * | 1998-06-03 | 2007-04-25 | 斯科特实验室公司 | 为患者缓解与内科或外科处理相关的痛苦的设备和方法 |
WO2000002620A1 (en) * | 1998-07-13 | 2000-01-20 | Genetronics, Inc. | Method and apparatus for electrically assisted topical delivery of agents for cosmetic applications |
US6440934B1 (en) | 1998-10-13 | 2002-08-27 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
US20030166550A1 (en) * | 1999-08-27 | 2003-09-04 | Chiron Corporation | Angiogenically effective unit dose of FGF-2 and method of use |
AU6411199A (en) * | 1998-10-13 | 2000-05-01 | Chiron Corporation | Angiogenically effective unit dose of fgf and method of administering |
US20020072489A1 (en) * | 1998-10-13 | 2002-06-13 | Whitehouse Martha J. | Angiogenically effective unit dose of FGF-2 and method of use |
US6475514B1 (en) | 1998-12-03 | 2002-11-05 | Andrew Blitzer | Athletic patch |
US6361522B1 (en) * | 1999-10-21 | 2002-03-26 | Cardiac Pacemakers, Inc. | Drug delivery system for implantable cardiac device |
US11087873B2 (en) | 2000-05-18 | 2021-08-10 | Carefusion 303, Inc. | Context-aware healthcare notification system |
US7860583B2 (en) | 2004-08-25 | 2010-12-28 | Carefusion 303, Inc. | System and method for dynamically adjusting patient therapy |
EP1316048A2 (en) | 2000-05-18 | 2003-06-04 | ALARIS Medical Systems, Inc. | Distributed remote asset and medication management drug delivery system |
US9069887B2 (en) * | 2000-05-18 | 2015-06-30 | Carefusion 303, Inc. | Patient-specific medication management system |
US9427520B2 (en) | 2005-02-11 | 2016-08-30 | Carefusion 303, Inc. | Management of pending medication orders |
US10062457B2 (en) | 2012-07-26 | 2018-08-28 | Carefusion 303, Inc. | Predictive notifications for adverse patient events |
US10353856B2 (en) | 2011-03-17 | 2019-07-16 | Carefusion 303, Inc. | Scalable communication system |
US9741001B2 (en) | 2000-05-18 | 2017-08-22 | Carefusion 303, Inc. | Predictive medication safety |
DE60129972T2 (de) | 2000-06-30 | 2008-05-08 | Lifewaves International, Inc. | System zur bewertung und veränderung der physiologischen kondition eines individuums |
US7369890B2 (en) | 2000-11-02 | 2008-05-06 | Cardiac Pacemakers, Inc. | Technique for discriminating between coordinated and uncoordinated cardiac rhythms |
US6689117B2 (en) | 2000-12-18 | 2004-02-10 | Cardiac Pacemakers, Inc. | Drug delivery system for implantable medical device |
US7209783B2 (en) * | 2001-06-15 | 2007-04-24 | Cardiac Pacemakers, Inc. | Ablation stent for treating atrial fibrillation |
US7493162B2 (en) * | 2001-06-15 | 2009-02-17 | Cardiac Pacemakers, Inc. | Pulmonary vein stent for treating atrial fibrillation |
US7340303B2 (en) | 2001-09-25 | 2008-03-04 | Cardiac Pacemakers, Inc. | Evoked response sensing for ischemia detection |
AU2002350108B2 (en) * | 2001-11-01 | 2008-09-11 | Scott Laboratories, Inc. | User interface for sedation and analgesia delivery systems and methods |
US8775196B2 (en) | 2002-01-29 | 2014-07-08 | Baxter International Inc. | System and method for notification and escalation of medical data |
US10173008B2 (en) | 2002-01-29 | 2019-01-08 | Baxter International Inc. | System and method for communicating with a dialysis machine through a network |
US20030140928A1 (en) * | 2002-01-29 | 2003-07-31 | Tuan Bui | Medical treatment verification system and method |
US7236821B2 (en) * | 2002-02-19 | 2007-06-26 | Cardiac Pacemakers, Inc. | Chronically-implanted device for sensing and therapy |
MXPA04010285A (es) * | 2002-04-18 | 2005-02-03 | Cv Therapeutics Inc | Metodo para tratar arritmias que comprende la administracion de un agonista de adenosina a1 con un bloqueador beta, bloqueador del canal de calcio o un glucosido cardiaco. |
US20040176667A1 (en) * | 2002-04-30 | 2004-09-09 | Mihai Dan M. | Method and system for medical device connectivity |
US20040172301A1 (en) * | 2002-04-30 | 2004-09-02 | Mihai Dan M. | Remote multi-purpose user interface for a healthcare system |
US20040167804A1 (en) * | 2002-04-30 | 2004-08-26 | Simpson Thomas L.C. | Medical data communication notification and messaging system and method |
US20040172300A1 (en) * | 2002-04-30 | 2004-09-02 | Mihai Dan M. | Method and system for integrating data flows |
US20050065817A1 (en) * | 2002-04-30 | 2005-03-24 | Mihai Dan M. | Separation of validated information and functions in a healthcare system |
US8234128B2 (en) | 2002-04-30 | 2012-07-31 | Baxter International, Inc. | System and method for verifying medical device operational parameters |
AU2003278896B2 (en) * | 2002-06-20 | 2009-10-01 | The Governors Of The University Of Alberta | Dichloroacetate in combination with cardioprotective or hemodynamic drugs |
US7089055B2 (en) * | 2002-06-28 | 2006-08-08 | Cardiac Pacemakers, Inc. | Method and apparatus for delivering pre-shock defibrillation therapy |
US7539537B2 (en) | 2002-10-03 | 2009-05-26 | Scott Laboratories, Inc. | Systems and methods for providing sensor fusion |
JP2006503617A (ja) * | 2002-10-03 | 2006-02-02 | スコット・ラボラトリーズ・インコーポレイテッド | 鎮静・鎮痛システムにおいて傾向分析を行うシステムおよび方法 |
US7072711B2 (en) | 2002-11-12 | 2006-07-04 | Cardiac Pacemakers, Inc. | Implantable device for delivering cardiac drug therapy |
US7627373B2 (en) | 2002-11-30 | 2009-12-01 | Cardiac Pacemakers, Inc. | Method and apparatus for cell and electrical therapy of living tissue |
US20090285900A1 (en) * | 2003-07-31 | 2009-11-19 | Robinson Cynthia B | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20050113318A1 (en) * | 2003-07-31 | 2005-05-26 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US20050026884A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease |
US7320675B2 (en) | 2003-08-21 | 2008-01-22 | Cardiac Pacemakers, Inc. | Method and apparatus for modulating cellular metabolism during post-ischemia or heart failure |
GB0403864D0 (en) * | 2004-02-20 | 2004-03-24 | Ucl Ventures | Modulator |
US7840263B2 (en) | 2004-02-27 | 2010-11-23 | Cardiac Pacemakers, Inc. | Method and apparatus for device controlled gene expression |
US7764995B2 (en) | 2004-06-07 | 2010-07-27 | Cardiac Pacemakers, Inc. | Method and apparatus to modulate cellular regeneration post myocardial infarct |
US7567841B2 (en) | 2004-08-20 | 2009-07-28 | Cardiac Pacemakers, Inc. | Method and apparatus for delivering combined electrical and drug therapies |
CN102512187B (zh) | 2004-11-16 | 2015-08-12 | 拜耳医疗保健公司 | 对病人体内的药物传播建模的系统和方法 |
JP5232473B2 (ja) | 2004-11-24 | 2013-07-10 | メドラッド インコーポレーテッド | 注入処理中に生成される圧力をモデル化するためのシステム及び装置 |
US7981065B2 (en) | 2004-12-20 | 2011-07-19 | Cardiac Pacemakers, Inc. | Lead electrode incorporating extracellular matrix |
US8060219B2 (en) | 2004-12-20 | 2011-11-15 | Cardiac Pacemakers, Inc. | Epicardial patch including isolated extracellular matrix with pacing electrodes |
US7616990B2 (en) | 2005-10-24 | 2009-11-10 | Cardiac Pacemakers, Inc. | Implantable and rechargeable neural stimulator |
US8182443B1 (en) | 2006-01-17 | 2012-05-22 | Masimo Corporation | Drug administration controller |
US7820721B2 (en) * | 2006-01-25 | 2010-10-26 | Wellstat Therapeutics Corporation | Compounds for the treatment of metabolic disorders |
JP5486315B2 (ja) | 2006-12-29 | 2014-05-07 | メドラッド インコーポレーテッド | 医療用注入手順用に患者ベースのパラメータを生成するシステム |
WO2008092257A1 (en) * | 2007-01-29 | 2008-08-07 | National Research Council Of Canada | Use of catecholamines and related compounds as anti-angiogenic agents |
CN103976736B (zh) | 2007-07-17 | 2017-01-11 | 拜耳医药保健有限责任公司 | 确定心肺功能评估和输液过程的参数的设备和系统 |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
US8057679B2 (en) | 2008-07-09 | 2011-11-15 | Baxter International Inc. | Dialysis system having trending and alert generation |
US10089443B2 (en) | 2012-05-15 | 2018-10-02 | Baxter International Inc. | Home medical device systems and methods for therapy prescription and tracking, servicing and inventory |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
CA2737461A1 (en) | 2008-09-19 | 2010-03-25 | Tandem Diabetes Care, Inc. | Solute concentration measurement device and related methods |
US8554579B2 (en) | 2008-10-13 | 2013-10-08 | Fht, Inc. | Management, reporting and benchmarking of medication preparation |
US9421330B2 (en) * | 2008-11-03 | 2016-08-23 | Bayer Healthcare Llc | Mitigation of contrast-induced nephropathy |
EP3284494A1 (en) | 2009-07-30 | 2018-02-21 | Tandem Diabetes Care, Inc. | Portable infusion pump system |
US20110137297A1 (en) * | 2009-09-17 | 2011-06-09 | Kiani Massi Joe E | Pharmacological management system |
CN103221071B (zh) | 2010-06-24 | 2016-09-21 | 拜耳医药保健有限公司 | 药物传输的建模和注射方案的参数产生 |
US9949704B2 (en) | 2012-05-14 | 2018-04-24 | Bayer Healthcare Llc | Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US8761717B1 (en) | 2012-08-07 | 2014-06-24 | Brian K. Buchheit | Safety feature to disable an electronic device when a wireless implantable medical device (IMD) is proximate |
US10552577B2 (en) | 2012-08-31 | 2020-02-04 | Baxter Corporation Englewood | Medication requisition fulfillment system and method |
NZ707430A (en) | 2012-10-26 | 2016-04-29 | Baxter Corp Englewood | Improved work station for medical dose preparation system |
EP3346444B1 (en) | 2012-10-26 | 2020-09-23 | Baxter Corporation Englewood | Improved image acquisition for medical dose preparation system |
US10430554B2 (en) | 2013-05-23 | 2019-10-01 | Carefusion 303, Inc. | Medication preparation queue |
US11182728B2 (en) | 2013-01-30 | 2021-11-23 | Carefusion 303, Inc. | Medication workflow management |
US9946844B2 (en) * | 2013-02-22 | 2018-04-17 | Cloud Dx, Inc. | Systems and methods for monitoring patient medication adherence |
EP4195119A1 (en) | 2013-03-13 | 2023-06-14 | Carefusion 303 Inc. | Predictive medication safety |
CN105074765B (zh) | 2013-03-13 | 2022-05-24 | 康尔福盛303公司 | 患者特有的用药管理系统 |
US9555379B2 (en) | 2013-03-13 | 2017-01-31 | Bayer Healthcare Llc | Fluid path set with turbulent mixing chamber, backflow compensator |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
EP3000094A4 (en) | 2013-05-22 | 2017-02-01 | Carefusion 303 Inc. | Medication workflow management |
EP3161778A4 (en) | 2014-06-30 | 2018-03-14 | Baxter Corporation Englewood | Managed medical information exchange |
US11575673B2 (en) | 2014-09-30 | 2023-02-07 | Baxter Corporation Englewood | Central user management in a distributed healthcare information management system |
US11107574B2 (en) | 2014-09-30 | 2021-08-31 | Baxter Corporation Englewood | Management of medication preparation with formulary management |
WO2016090091A1 (en) | 2014-12-05 | 2016-06-09 | Baxter Corporation Englewood | Dose preparation data analytics |
EP3800610A1 (en) | 2015-03-03 | 2021-04-07 | Baxter Corporation Englewood | Pharmacy workflow management with integrated alerts |
CN107810536B (zh) | 2015-06-25 | 2023-01-24 | 甘布罗伦迪亚股份公司 | 具有分布式数据库的医疗装置系统和方法 |
WO2017152036A1 (en) | 2016-03-03 | 2017-09-08 | Bayer Healthcare Llc | System and method for improved fluid delivery in multi-fluid injector systems |
WO2018114346A1 (en) | 2016-12-21 | 2018-06-28 | Gambro Lundia Ab | Medical device system including information technology infrastructure having secure cluster domain supporting external domain |
JP7346309B2 (ja) | 2017-08-31 | 2023-09-19 | バイエル・ヘルスケア・エルエルシー | 流体送達性能を改善するための流体経路インピーダンス評価 |
AU2018326485B2 (en) | 2017-08-31 | 2024-01-04 | Bayer Healthcare Llc | Injector pressure calibration system and method |
CN110809482B (zh) | 2017-08-31 | 2023-03-07 | 拜耳医药保健有限公司 | 流体注入器系统体积补偿系统和方法 |
WO2019046260A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | METHOD FOR CONTROLLING DYNAMIC PRESSURE IN A FLUID INJECTOR SYSTEM |
CA3067740A1 (en) | 2017-08-31 | 2019-03-07 | Bayer Healthcare Llc | Method for drive member position and fluid injection system mechanical calibration |
US11969576B2 (en) | 2019-07-03 | 2024-04-30 | Tandem Diabetes Care, Inc. | Methods of incorporating CGM data into diabetes therapy |
US11654236B2 (en) | 2019-11-22 | 2023-05-23 | Tandem Diabetes Care, Inc. | Systems and methods for automated insulin delivery for diabetes therapy |
US11911595B2 (en) | 2020-05-18 | 2024-02-27 | Tandem Diabetes Care, Inc. | Systems and methods for automated insulin delivery response to meal announcements |
Family Cites Families (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA570892A (en) * | 1959-02-17 | D. Moed Hendrik | Method of producing substituted aralkyl-, phenyl-, alkylamines | |
DE1144291B (de) * | 1957-11-05 | 1963-02-28 | Philips Nv | Verfahren zur Herstellung einer optisch-aktiven broncholytisch wirksamen Verbindung |
US3135797A (en) * | 1958-04-15 | 1964-06-02 | Colgate Palmolive Co | Aromatic amino antispasmodic compounds |
US3319623A (en) * | 1964-07-13 | 1967-05-16 | Seymour B London | Blood pressure monitors |
US3969410A (en) * | 1972-01-12 | 1976-07-13 | Boehringer Ingelheim Gmbh | 1-(2'-Alkyl-3',4'-dihydroxy-phenyl)-2-(phenylalkyl-amino)-alkanols-(1) and salts thereof |
US3803320A (en) * | 1968-07-24 | 1974-04-09 | Geigy Chem Corp | Control of insects,acarinae and nematodes with basically substituted 1-cyano-o-carbamoyl-formoximes |
US3803230A (en) * | 1969-05-30 | 1974-04-09 | Allen & Hanburys Ltd | 5-(2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide hydrochloride |
US3651806A (en) * | 1969-10-24 | 1972-03-28 | Philip I Hirshberg | Method and apparatus for administering digitalizing medications |
US4086272A (en) * | 1970-07-18 | 1978-04-25 | Pfizer Inc. | Phenyl-alkanolamine, alkylamine and alpha-aminoalkyl ketone derivatives as heart stimulants |
GB1301134A (en) * | 1970-07-18 | 1972-12-29 | Pfizer Ltd | SUBSTITUTED 1-PHENYL-2-ALLYLAMINO-ALKANOLS, 1-PHENYL-2-ALLYLAMINO-ALKANES AND alpha-AMINOALKYLPHENYL KETONES |
NL7112938A (el) * | 1970-09-30 | 1972-04-05 | ||
US3987200A (en) * | 1972-04-12 | 1976-10-19 | Eli Lilly And Company | Method for increasing cardiac contractility |
JPS5310582B2 (el) * | 1973-04-28 | 1978-04-14 | ||
FR2328456A1 (fr) * | 1975-10-22 | 1977-05-20 | Bruneau & Cie Lab | Derives de phenylethanolamine, leur preparation et leur application en therapeutique |
US4080966A (en) * | 1976-08-12 | 1978-03-28 | Trustees Of The University Of Pennsylvania | Automated infusion apparatus for blood pressure control and method |
US4078562A (en) * | 1976-08-16 | 1978-03-14 | Diana W. Friedman | Infusion pump with feedback control |
US4141359A (en) * | 1976-08-16 | 1979-02-27 | University Of Utah | Epidermal iontophoresis device |
SE402569B (sv) * | 1976-11-09 | 1978-07-10 | Aga Ab | Anordning vid en andningsapparat for dykare |
FI791727A (fi) * | 1978-06-05 | 1979-12-06 | Ciba Geigy Ag | Foerfarande foer framstaellning av n-alkylerade aminoalkoholer |
DE2965655D1 (en) * | 1978-06-28 | 1983-07-21 | Beecham Group Plc | Secondary amines, their preparation, pharmaceutical compositions containing them and their use |
DK269079A (da) * | 1978-07-03 | 1980-02-01 | Lilly Co Eli | Fremgangsmaade til fremstilling af phenethanolaminer |
US4845127A (en) * | 1978-07-03 | 1989-07-04 | Eli Lilly And Company | Phenethanolamines, compositions containing the same and method for effecting weight control |
DE3061205D1 (en) * | 1979-06-16 | 1983-01-05 | Beecham Group Plc | Secondary amines, their preparation and use in pharmaceutical compositions |
US4280494A (en) * | 1979-06-26 | 1981-07-28 | Cosgrove Robert J Jun | System for automatic feedback-controlled administration of drugs |
US4392849A (en) * | 1981-07-27 | 1983-07-12 | The Cleveland Clinic Foundation | Infusion pump controller |
GB2133986B (en) * | 1983-01-31 | 1987-08-26 | Lilly Co Eli | Animal feed compositions containing phenethanolamines |
US4837305A (en) * | 1983-02-03 | 1989-06-06 | The Regents Of The University Of California | Derivatives of β-adrenergic antagonists |
US5135479A (en) * | 1983-08-18 | 1992-08-04 | Drug Delivery Systems, Inc. | Programmable control and mounting system for transdermal drug applicator |
WO1986007269A1 (en) * | 1985-06-10 | 1986-12-18 | Drug Delivery Systems Inc. | Programmable control and mounting system for transdermal drug applicator |
EP0135905A3 (de) * | 1983-09-29 | 1986-10-22 | ASTA Pharma Aktiengesellschaft | Neue 1-(Alkyl-hydroxy-phenyl)-1-hydroxy-2-(alkylamino)-propane |
US4562206A (en) * | 1983-12-23 | 1985-12-31 | Key Pharmaceuticals, Inc. | Orally effective inotropic compounds |
US4865584A (en) * | 1984-02-08 | 1989-09-12 | Omni-Flow, Inc. | Cassette for programable multiple input infusion system |
CA1254091A (en) * | 1984-09-28 | 1989-05-16 | Vladimir Feingold | Implantable medication infusion system |
US5088981A (en) * | 1985-01-18 | 1992-02-18 | Howson David C | Safety enhanced device and method for effecting application of a therapeutic agent |
US4688577A (en) * | 1986-02-10 | 1987-08-25 | Bro William J | Apparatus for and method of monitoring and controlling body-function parameters during intracranial observation |
US4722726A (en) * | 1986-02-12 | 1988-02-02 | Key Pharmaceuticals, Inc. | Method and apparatus for iontophoretic drug delivery |
EP0313638A4 (en) * | 1987-05-15 | 1989-06-14 | Martin H Newman | IONTOPHORESIS INOPHORESIS DRUG ADMINISTRATION SYSTEM. |
US4931046A (en) * | 1987-05-15 | 1990-06-05 | Newman Martin H | Iontophoresis drug delivery system |
US5108363A (en) * | 1988-02-19 | 1992-04-28 | Gensia Pharmaceuticals, Inc. | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist |
US4846792A (en) * | 1988-03-08 | 1989-07-11 | Baxter International Inc. | Automatic infiltration detection system and method |
-
1989
- 1989-02-09 US US07/308,683 patent/US5108363A/en not_active Expired - Fee Related
- 1989-02-15 NZ NZ239270A patent/NZ239270A/xx unknown
- 1989-02-17 IE IE960742A patent/IE80716B1/en not_active IP Right Cessation
- 1989-02-17 DE DE68928422T patent/DE68928422T2/de not_active Expired - Fee Related
- 1989-02-17 IE IE52689A patent/IE71651B1/en not_active IP Right Cessation
- 1989-02-17 EP EP95101920A patent/EP0658538B1/en not_active Expired - Lifetime
- 1989-02-17 AT AT95101920T patent/ATE159710T1/de not_active IP Right Cessation
- 1989-02-17 ES ES89301553T patent/ES2081299T3/es not_active Expired - Lifetime
- 1989-02-17 AT AT89301553T patent/ATE129644T1/de not_active IP Right Cessation
- 1989-02-17 DK DK073589A patent/DK73589A/da not_active Application Discontinuation
- 1989-02-17 EP EP89301553A patent/EP0329464B1/en not_active Expired - Lifetime
- 1989-02-17 ES ES95101920T patent/ES2111973T3/es not_active Expired - Lifetime
- 1989-02-17 AU AU30088/89A patent/AU634152B2/en not_active Ceased
- 1989-02-17 FI FI890776A patent/FI890776A/fi not_active Application Discontinuation
- 1989-02-17 DE DE68924661T patent/DE68924661T2/de not_active Expired - Fee Related
- 1989-02-20 JP JP1042887A patent/JP2806543B2/ja not_active Expired - Lifetime
- 1989-02-20 NO NO89890704A patent/NO890704L/no unknown
-
1990
- 1990-12-11 US US07/625,362 patent/US5286252A/en not_active Expired - Fee Related
-
1993
- 1993-12-07 US US08/163,839 patent/US5460605A/en not_active Expired - Fee Related
- 1993-12-15 US US08/169,536 patent/US5395970A/en not_active Expired - Fee Related
-
1996
- 1996-01-24 GR GR960400162T patent/GR3018764T3/el unknown
-
1998
- 1998-01-14 GR GR980400065T patent/GR3025892T3/el unknown
- 1998-02-19 JP JP10037422A patent/JPH10276991A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO890704L (no) | 1989-08-21 |
EP0329464A2 (en) | 1989-08-23 |
ES2081299T3 (es) | 1996-03-01 |
JPH10276991A (ja) | 1998-10-20 |
IE890526L (en) | 1989-08-19 |
US5286252A (en) | 1994-02-15 |
NZ239270A (en) | 1993-10-26 |
IE71651B1 (en) | 1997-02-26 |
NO890704D0 (no) | 1989-02-20 |
DK73589A (da) | 1989-08-20 |
DE68928422D1 (de) | 1997-12-04 |
US5395970A (en) | 1995-03-07 |
EP0658538B1 (en) | 1997-10-29 |
US5460605A (en) | 1995-10-24 |
JP2806543B2 (ja) | 1998-09-30 |
IE960742L (en) | 1989-08-19 |
FI890776A0 (fi) | 1989-02-17 |
AU3008889A (en) | 1989-08-24 |
GR3018764T3 (en) | 1996-04-30 |
JPH0217048A (ja) | 1990-01-22 |
DE68924661T2 (de) | 1996-03-21 |
EP0329464B1 (en) | 1995-11-02 |
IE80716B1 (en) | 1998-12-30 |
DE68924661D1 (de) | 1995-12-07 |
EP0658538A1 (en) | 1995-06-21 |
ATE159710T1 (de) | 1997-11-15 |
FI890776A (fi) | 1989-08-20 |
ATE129644T1 (de) | 1995-11-15 |
ES2111973T3 (es) | 1998-03-16 |
EP0329464A3 (en) | 1991-07-17 |
US5108363A (en) | 1992-04-28 |
AU634152B2 (en) | 1993-02-18 |
DK73589D0 (da) | 1989-02-17 |
DE68928422T2 (de) | 1998-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3025892T3 (en) | Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist. | |
DE3887152D1 (de) | Vorrichtung zum Testen oder Trainieren der unteren Rumpfmuskeln des menschlichen Körpers. | |
DE3267341D1 (en) | Exercising apparatus | |
DE69411739D1 (de) | Prüfung von peripheren gefässerkrankungen | |
MY113750A (en) | Running body and racing game apparatus using the same | |
Kellogg et al. | " Ambiguous conditioning," a phenomenon of bilateral transfer. | |
Caspy et al. | Generality of US preexposure effects: Effect of shock or food preexposure on water escape | |
Baras | Effect of mode of presentation on semantic satiation | |
Wray Jr et al. | Effect of continuous load on the mechanical properties of tendon adhesions | |
Bean-Bayog et al. | Special report: AMSAODD: Plan for certification of members, 1985–1986. | |
OISHI et al. | Time to peak force and force developing speed during fast maximal and submaximal isometric voluntary contractions | |
Hoyes Beehler et al. | Stimulus intensity and experimental design effects on motor response processing | |
FR2556958B1 (fr) | Appareil de detection, diagnostic et soins suivant l'acupuncture magnetique et bio-magnetique | |
Craig | The Importance of strength training for seniors | |
Caldwell | Classical conditioning I: Its utilization in producing abnormal breathing in sheep | |
Schuh et al. | Laboratory diagnosis in buiatric practice. 7. Analysis of mycotoxins, bacteria and fungi in different feedstuffs. | |
Repo | The holistic approach to rehabilitation: a commentary | |
Tal'nov et al. | The effect of microstimulation of the motor cortex on the myotatic muscle reflexes of the elbow joint in the nonanesthetized cat | |
RU95101695A (ru) | Тренажер ветеринарный | |
Stuberg | Morphometric analysis of skeletal muscle in exercised normal and dystrophic hamsters. | |
Volz | Fatigue-related characteristics of the soleus and extensor digitorum longus muscles in small and large cage-reared female rats | |
Steele | Behavioural conditioning in managemnent of captive pinnipeds | |
SE8305679D0 (sv) | Treningsanordning for benmuskulatur, cirkulation och armmuskulatur | |
Buckner | THE EFFECTS OF A HEALTH EDUCATION INCENTIVE PROGRAM ON PHYSIOLOGICAL AND PSYCHOLOGICAL VARIABLES. | |
Moon | Structural and functional integration of the snake axial system |